Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies

Cancer

Volumn 105, Issue 2, 2005, Pages 87-95

  Rossi, Esther D ^a   Raffaelli, Marco ^a   Minimo, Corrado ^b   Mule, Antonino ^a   Lombardi, Celestino P ^a   Vecchio, Fabio M ^a   Fadda, Guido ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Fine needle aspiration; Immunocytochemistry; Thin layer cytology; Thyroid neoplasm

Indexed keywords

ANTIBODY; GALECTIN 3; HBME 1 ANTIGEN; PROTEIN RET; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CELL PROLIFERATION; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; EVALUATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RELIABILITY; THYROID FOLLICLE CELL; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; ANTIBODIES; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; CYTODIAGNOSIS; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 18044372234     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21026     Document Type: Article

References (42)

1. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid. Ann Intern Med. 1993;118:282-289.
2. Michael CW, Hunter B. Interpretation of fine-needle aspirates processed by ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol. 2000;23:6-13.
3. Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, Groshen S, Singer P, Lopresti J, Martin SE. Follicular lesions of thyroid. A 5-year fine-needle aspiration experience. Cancer (Cancer Cytopathol). 2000;90:335-341.
4. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001;357:1644-1650.
5. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001;14:338-342.
6. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol. 1999;17:3494-3502.
7. Miettinen M, Kovatich AJ. HBME-1 monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma and soft tissue and bone tumors. Appl Immunohistochem. 1995;3:115-122.
8. Nakamura T, Ishizaka Y, Nagao M, Hara M, Ishikawa T. Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J Pathol. 1994;172:255-260.
9. Zhang Y, Fraser JL, Wang HH. Morphologic predictors of papillary carcinoma on fine-needle aspiration of thyroid with ThinPrep preparations. Diagn Cytopathol. 2001;24:378-383.
10. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T. Expression of Galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer. 1999;85:2475-2484.
11. Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A, Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol. 2002;147:515-521.
12. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM, Baloch ZW. Immunohistochemical expression of Galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med. 2002;126:710-713.
13. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology. 2002;40:80-87.
14. Fadda G, Rabitti C, Minimo C, Ieraci A, Verzi A, Bianchi A, Lancia M, Gullotta G, Capelli A. Morphologic and planimetric diagnosis of follicular thyroid lesions on fine-needle aspiration cytology. Anal Quant Cytol Histol 1995;17:247-256.
15. Fadda G, Balsamo G, Fiorino MC, Mule A, Lombardi CP, Raffaelli M, Bellantone R. Follicular thyroid lesions and risk of malignancy: a new diagnostic classification on fine-needle aspiration cytology. J Exp Clin Cancer Res. 1998;17:103-107.
16. Buley ID. The thyroid gland. In: Gray W. Diagnostic cytopathology. Churchill Livingstone: London. 1995: pp 557-582.
17. Raz A, Zhu D, Hogan V, Shah N, Raz T, Korkash R, Pazerini G, Carmi P. Evidence for the role of a 34 kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer. 1990;46:871-877.
18. Chiarotti L, Berlingieri MT, De Rosa P, Battaglia C, Berger N, Bruni CB, Fusco A. Increased expression of the negative growth factor, galactoside-binding protein gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene. 1992;71:2507-2511.
19. Stephenson TJ. Papillary carcinoma of the thyroid: a tumor still with no benign counterpart. Histopathology. 2001;39:536-538.
20. Baloch ZW, Gupta PK, Yu GH, Sack MJ, Li Volsi VA. Follicular variant of papillary carcinoma. Cytologic and histologic correlation. Am J Clin Pathol 1999;111:216-222.
21. Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid:the bane of the pathologist. Am J Clin Pathol. 2002;117:143-150.
22. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26:41-44.
23. Poller DN, Ibrahim AK, Cummings MH, Mikel JJ, Boote D, Perry M. Fine-needle aspiration of the thyroid. Importance of an indeterminate diagnostic category. Cancer (Cancer Cytopathol) 2000;90:239-244.
24. Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma. A retrospective study in 37,895 patients. Cancer (Cancer Cytopathol). 2000;90:357-363.
25. Basolo F, Molinaro E, Agate L, Pinchera A, Pollina L, Chiappetta G, Monaco C, Santoro M, Fusco A, Miccoli P, Elisei R, Capezzone M, Pacini F. RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma. Eur J Endocrinol. 2001;145:599-604.
26. Miettinen M, Karkkainen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumors. Preferential reactivity with malignant tumours. Virchows Arch. 1996;429:213-219.
27. Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions: a paraffin section analysis with diagnostic implications. Virchows Arch. 1997;431:407-413.
28. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL. Analysis of RET/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol. Metab. 2001;86:2187-2190.
29. Holbrook MR, Kendall CH, Shaw AV. An alternate model of thyroid cytology: practical not perfect. Cytopathology 2003;14:121-126.
30. Afify AM, Liu J, Al-Khafaji BM. Cytologic artifacts and pitfalls of thyroid fine-needle aspiration using ThinPrep. Cancer (Cancer Cytopathol). 2001;93:179-186.
31. Scurry JP, Duggan MA. Thin layer compared to direct smear in thyroid fine-needle aspiration. Cytopathology. 2000;11:104-115.
32. Lee KR, Papillo JL, St John T, Eyerer GJ. Evaluation of the Thin Prep processor for fine needle aspiration specimens. Acta Cytol. 1996;40:895-899.
33. Biscotti CV, Hollow JA, Toddy SM, Easley KA. ThinPrep versus conventional smears cytological preparations in the analysis of thyroid fine-needle aspiration specimens. Am J Clin Pathol. 1995;104:150-153.
34. Frost AR, Sidawy MK, Ferfelli M, Tabbara SO, Bronner NA, Brosky KR, Sherman ME. Utility of thin-layer preparations in thyroid fine-needle aspiration. Cancer (Cancer Cytopathol). 1998;84:17-25.
35. Nasuti JF, Tam D, Gupta PK. Diagnostic value of liquid-based (Thin Prep) preparations in nongynecologic cases. Diagn Cytopathol. 2001;24:137-141.
36. Leung SW, Bedard YC. Immunocytochemical staining on ThinPrep processed smears. Mod Pathol. 1996;9:304-306.
37. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA. HBME-1 immunostaining in thyroid fine-needle aspirations:a useful marker in the diagnosis of carcinoma. Mod Pathol. 1997;10:668-674.
38. Tielens ET, Sherman ST, Hruben RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study. Cancer. 1994;73:424-431.
39. Beesley MF, McLaren KM. Cytokeratin 19 and Galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology. 2002;41:236-243.
40. Dabbs D, Abendroth CS, Grenko RT, Wang X, Gail ER. Immunocytochemistry on the Thin-Prep Processor. Diagn Cytopathol. 1997;17:388-392.
41. Tabbara SO, Sidaway MK, Frost AR, Brosky KR, Coles V, Hecht S, Radcliffe G, Sherman ME. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as Preservcyt Suspension and as Thin-Prep slides. Cancer (Cancer Cytopathol). 1998;84:355-360.
42. Cochand-Priollet B, Prat JJ, Polivka M, Thienpont L, Dahan H, Wassef M, Guillausseau PJ. Thyroid fine needle aspiration: the morphological features on ThinPrep slide preparations. Eighty cases with histological control. Cytopathology. 2003;14:343-349.